Jazz Pharmaceuticals plc — Director's Dealing 2017

Mar 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2017-03-06

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-06	Ordinary Shares	F	563	$132.81	Disposed	18762	Direct
2017-03-08	Ordinary Shares	M	2896	$46.83	Acquired	21658	Direct
2017-03-08	Ordinary Shares	M	750	$59.13	Acquired	22408	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-08	Incentive Stock Option (right to buy)	$46.83	M	2896	Disposed	2022-08-08	Ordinary Shares (2896)	Direct
2017-03-08	Incentive Stock Option (right to buy)	$59.13	M	750	Disposed	2023-03-04	Ordinary Shares (750)	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested over four years measured from the grant date, August 9, 2012, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

F3: This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested over four years measured from the grant date, March 5, 2013, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.